Sisram Medical Ltd.

As of December 31, 2025, SISRAM MED LTD. carries a market capitalization of 392.04M, placing it among publicly traded companies globally. Its enterprise value stands at 396.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SISRAM MED LTD.'s next confirmed earnings release is scheduled for March 24, 2027.

As of December 31, 2025, SISRAM MED LTD. has 468.34M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, SISRAM MED LTD. maintains a current ratio of 2.60, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on August 28, 2026, SISRAM MED LTD.'s stock has declined approximately 89.99% over the past 52 weeks.

As of December 31, 2025, SISRAM MED LTD. holds 70.97M in cash and equivalents against 51.75M in total debt, resulting in a net debt position of -60.18M. Total book value stands at 479.85M, with working capital of 170.04M providing operational flexibility.